Usefulness of a molecular strategy for the detection of bacterial DNA in patients with severe sepsis undergoing continuous renal replacement therapy

Blood Purification

Volumn 25, Issue 1, 2006, Pages 106-111

  Ratanarat, Ranistha ^a,c   Cazzavillan, Stefania ^a   Ricci, Zaccaria ^b   Rassu, Mario ^a   Segala, Chiara ^a   Decal, Massimo ^a   Cruz, Dinna ^a   Corradi, Valentina ^a   Manfro, Stefania ^a   Roessler, Eric ^a   Levin, Nathan ^d   Ronco, Claudio ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c MAHIDOL UNIVERSITY   (Thailand)

^d RENAL RESEARCH INSTITUTE   (United States)

Author keywords

Continuous renal replacement therapy; DNA, bacterial; Renal failure, acute; Sepsis; Ultrafiltrate

Indexed keywords

BACTERIAL DNA; RIBOSOME RNA;

ACUTE KIDNEY FAILURE; ADULT; AGED; BLOOD CULTURE; CLINICAL ARTICLE; COHORT ANALYSIS; CONFERENCE PAPER; CONTINUOUS RENAL REPLACEMENT THERAPY; DIAGNOSTIC ACCURACY; DIALYSATE; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; HEMOFILTRATION; HUMAN; INTERMETHOD COMPARISON; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEPSIS; SEQUENCE ANALYSIS; ULTRAFILTRATION;

ADULT; AGED; COHORT STUDIES; COLONY COUNT, MICROBIAL; CRITICAL ILLNESS; DNA, BACTERIAL; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SEPSIS;

EID: 33845753436     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096406     Document Type: Conference Paper

References (21)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
2. Pittet D, Thiévent B, Wenzel RP, et al: Bedside prediction of mortality from bacteremia sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996;153:684-693.
3. Kollef MH, Sherman G, Ward S, et al: Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-474.
4. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117-123.
5. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR, Black E, Schwartz JS, Moore R, Johnson BL Jr, Platt R; Academic Medical Center Consortium Sepsis Project Working Group: Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997;27:234-240.
6. Wu TL, Zhang D, Chia JH, Tsao KH, Sun CF, Wu JT: Cell-free DNA: Measurement in various carcinomas and establishment of normal reference range. Clin Chim Acta 2002;321:77-87.
7. Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett DE: Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care 2006;10:R60.
8. Bone RC, Sibbald WJ, Sprung CL: The ACCPSCCM consensus conference on sepsis and organ failure. Chest 1992;101:1481-1483.
9. Dellinger RP, Carlet JM, Masur H, et al: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004;30:536-555.
10. Mylotte JM, Tayara A: Blood cultures: clinical aspects and controversies. Eur J Clin Microbiol Infect Dis 2000;19:157-163.
11. Woese CR, Stackebrandt E, Macke TJ, Fox GE: A phylogenetic definition of the major eubacterial taxa. Syst Appl Microbiol 1985;6:143-151.
12. Woese CR: Bacterial evolution. Microbiol Rev 1987;51:221-281.
13. Clarridge JE: Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev 2004;17:840-862. http://cmr.asm.org/cgi/reprint/17/4/840
14. Bellomo R, Ronco C, Kellum JA, Mehta R, Palevsky P; the ADQI Workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-R212.
15. Ricci Z, Salvatori G, Bonello M, Bolgan I, D'Amico G, Dan M, Piccinni P, Ronco C: In vivo validation of the adequacy calculator for continuous renal replacement therapies. Crit Care 2005;9:R266-R273.
16. Klaerner H-G, Eschenbach U, Kamereck K, Lehn N, Wagner H, Miethke T: Failure of an automated blood culture system to detect nonfermentative gram-negative bacteria. J Clin Microbiol 2000;38:1036-1041.
17. Shigei JT, Shimabukuro JA, Pezzlo MT, de la Maza LM, Peterson EM: Value of terminal subcultures for blood cultures monitored by BACTEC 9240. J Clin Microbiol 1995;33:1385-1388.
18. Smith JA, Bryce EA, Ngui-Yen JH, Roberts FJ: Comparison of BACTEC 9240 and BacT/Alert blood culture systems in an adult hospital. J Clin Microbiol 1995;33:1905-1908.
19. Venkataraman R, Subramanian S, Kellum JA: Clinical review: extracorporeal blood purification in severe sepsis. Crit Care 2003;7:139-145.
20. Terry TM: Microbial metabolism: the synthetic of nucleic acids and proteins; in Prescott L, Harley J, Klein D (eds): Microbiology, ed 4. Boston, McGraw-Hill, 1999, pp 212-225.
21. Hansard PC, Haseeb MA, Manning RA, Salwen MJ: Recovery of bacteria by continuous renal replacement therapy in septic shock and by ultrafiltration from an in vitro model of bacteremia. Crit Care Med 2004;32:932-937.